Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

	News, Updates and Commentary
	News RSS Feed

Free Newsletter

We value your privacy. We will not rent your email to anyone.

Studies conducted at University of Massachusetts, Medical Department on hepatitis C virus recently published
- (NewsRx.com) -- 'Hepatic gene transfer is envisioned as a substitute for protein replacement therapies, many of which are derived from blood products (see also ). Thus, the target populations may have a high prevalence of blood-borne pathogens, such as

Data on hepatitis C virus published by researchers at Federal University
- (NewsRx.com) -- According to recent research from Campo Grande, Brazil, 'A survey was conducted among the hemodialysis units of the city of Campo Grande, located in the state of Mato Grosso do Sul in the Mid-west region of Brazil, with the aim of

Reports on hepatitis B virus therapy findings from Konkuk University, Department of Internal Medicine provide new insights
- (NewsRx.com) -- Research findings, 'Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment,' are discussed in a new report (see also Hepatitis B Virus Therapy). According to recent research

UPDATES AND COMMENTARY

The Hepatitis Vaccine That Does Double Duty
People who have Hepatitis C and have not been vaccinated against Hepatitis A or Hepatitis B could benefit from the combined hepatitis vaccine....

Medical Spas May Pose Hepatitis Risk
Since medical spas are offering more treatments involving the use of needles, the potential for Hepatitis C transmission is rising. Learn about some of the spa treatment techniques that pose hepatitis transmission dangers, as well as five ways to increase...

Hepatitis B Treatment May Reduce Pancreatic Cancer Risk
While several theories are attempting to explain the connection, scientists are unsure why those with Hepatitis B appear to have a 2 1/2 fold increase in risk for developing pancreatic cancer. Once the link is understood, Hepatitis B treatment may...

Slow Progression Rate of Fibrosis in Hepatitis C Virus Patients With Persistently Normal Alanine Transaminase Activity

References

1. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832[ [ Link previously at www.ncbi.nlm.nih.gov ]].

2. Alter MJ, Marcolis HS, Krawczyski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905[ [ Link previously at www.ncbi.nlm.nih.gov ]].

3. Poynard T, Bedossa P, Metavir and Clinivir Cooperative Study Groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 1997; 4: 199-208[ [ Link previously at www.ncbi.nlm.nih.gov ]].

4. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995; 21: 285-290[ Abstract].

5. Stanley AJ, Haydon GH, Piris J, Jarvis LM, Hayes PC. Assessment of liver histology in patients with normal transaminase levels. Eur J Gastroenterol Hepatol 1996; 8: 869-872[ [ Link previously at www.ncbi.nlm.nih.gov ]].

6. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 397-398[ [ Link previously at www.ncbi.nlm.nih.gov ]].

7. Yuki N, Hayashi N, Takehara T, Hagiwara H, Hiramatsu N, Naito M, Kawanishi Y, et al. Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol 1994; 89: 1462-1466[ [ Link previously at www.ncbi.nlm.nih.gov ]].

8. Brillanti S, Folli M, Gaiani S, Masci C, Migloli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet 1993; 341: 464-465[ [ Link previously at www.ncbi.nlm.nih.gov ]].

9. Prieto M, Olaso V, Verdu C, Cordoba J, Gisbert C, Rayon M, Carrasco D, et al. Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction. HEPATOLOGY 1995; 22: 413-417[ [ Link previously at www.ncbi.nlm.nih.gov ]].

10. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243[ [ Link previously at www.ncbi.nlm.nih.gov ]].

11. Kodama T, Tamamki T, Katabami S, Katamuma A, Yamashita H, Azuma N, Kamijo K, et al. Histological findings in asymptomatic hepatitis C virus carriers. J Gastroenterol Hepatol 1993; 8: 403-405[ [ Link previously at www.ncbi.nlm.nih.gov ]].

12. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. HEPATOLOGY 1995; 22: 418-425[ Abstract].

13. Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Polda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ 1994; 308: 697[ [ Link previously at www.ncbi.nlm.nih.gov ]].

14. Marcellin P, Gournay J, Cymes K, Martinot M, Benhamou JP, Degott C, Erlinger S. Liver histology in asymptomatic anti-HCV patients with normal ALT levels. HEPATOLOGY 1994; 20: 255A.

15. The METAVIR Cooperative Group. Inter and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. HEPATOLOGY 1994; 20: 15-20[ Abstract].

16. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al. A comparison of three interferon alpha-2b regimens for long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332: 1457-1462[ [ Link previously at www.ncbi.nlm.nih.gov ]].

17. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293[ Abstract].

18. Morisco F, Del Vecchio-Blanco G, Tucillo C, Iasevoli P, Sessa G, Caporaso N. Levels of HCV RNA in subjects with and without HCV-related chronic liver disease [Abstract]. J Hepatol 1995; 23(Suppl): A25.

19. Payen JL, Izopet J. Le statut de porteur sain du virus de l'hépatite C existe t-il? Gastroenterol Clin Biol 1996; 20: 531-534[ [ Link previously at www.ncbi.nlm.nih.gov ]].

20. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. HEPATOLOGY 1994; 19: 871-875[ Abstract].

21. Hagiwara H, Hayashi N, Mita E, Naito M, Kashara A, Fusamoto H, Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. HEPATOLOGY 1993; 17: 545-550[ Abstract].

22. Serfaty L, Chazouillères O, Pawlotsky JM, Andréani T, Pellet C, Poupon R. Level of viremia, genotype, histological features and effect of interferon (IFN) therapy in hepatitis C virus (HCV) carriers with persistently normal ALT activity. HEPATOLOGY 1994; 20: 165A.

Return To Article

table Of Contents

Copyright © 1998 by the American Association for the Study of Liver Diseases.

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 10 Oct 2008